Contact:  Joe Barbrie

EMED Technologies Corporation

Phone: (888) 550-6500

Extension 118

 

1264 Hawks, Flight Court

Suite 200

El Dorado Hills, CA 95762

www.emedtccom

emed technologies corp.

 

Press Release

EMED announces the launch of Soft-Glideª SCIg Infusion Sets

cid:image001.png@01CD013F.26BADBC0El Dorado Hills,   May 1, 2012:    EMED Technologies Corporation today announced the completed development and launch of its new line of Soft-Glideª Subcutaneous Immunoglobulin Infusion Sets.

 

Needle sharpness and patient pain associated with needle insertion and removal is a problem all needle manufacturers face.   EMED has been diligently working on the needle sharpness challenge and developed a sub-q needle we feel will be unsurpassed in the market.  We feel your patients will notice a big difference with EMEDÕs Soft-Glideª coating technology.  

 

This product was shown at the NHIA in Phoenix April 23-26 and was well-received.  Clinicians clearly noticed the ease of needle insertion and removal as compared to competitor needles.

This development further solidified EMEDÕs position as the market leader in this segment of the SCIg market.


EMED was the first company to design and market multi-needle subcutaneous infusion sets specifically for the SCIg patient.                                                                                                      

Headquartered in El Dorado Hills, CA , EMED develops, manufactures and markets medical devices worldwide.